Translation of the Frailty Paradigm from Older Adults to Children with Cardiac Disease

Chaitanya Panchangam1,2, David A White3,4, Suma Goudar3,4

  • 1Department of Child Health, University of Missouri Health Care, Columbia, MO, USA. panchangams@health.missouri.edu.

Insights

Children with cardiac disease (CCD) show significant deficits in all five frailty domains compared to healthy peers. This study quantifies frailty in CCD, highlighting a need for further research into its predictive value for health outcomes.

Area of Science:

  • Pediatric Cardiology
  • Gerontology
  • Clinical Assessment

Background:

  • Children and adolescents with cardiac disease (CCD) experience significant morbidity and reduced quality of life.
  • Currently, no widely applicable tools exist to assess functional phenotypes, encompassing physical capability and psychosocial well-being, in CCD, unlike the established frailty scores for the elderly.

Purpose of the Study:

  • To investigate the specific domains of frailty within the pediatric and adolescent cardiac disease population.
  • To establish whether frailty domains can be quantified using developmentally appropriate methods in CCD.
  • To compare frailty domain performance between CCD and age- and gender-matched healthy controls.

Main Methods:

  • Prospective recruitment of 34 children and adolescents with cardiac disease (ages 8-17.5) and 22 healthy controls.
  • Assessment of five frailty domains: slowness (6-min walk test), weakness (handgrip strength), exhaustion (multidimensional fatigue scale), body composition (height, weight, BMI, skinfold thickness), and physical activity (pediatric activity questionnaire).
  • Utilized age- and gender-based population norms to derive Z scores and percentiles for each measurement, followed by two-tailed t-tests for group comparisons.

Main Results:

  • The CCD group demonstrated significantly worse performance across all five assessed frailty domains compared to healthy controls.
  • Specific significant differences were observed in the 6-min walk test (slowness), handgrip strength (weakness), fatigue scale scores (exhaustion), and various body composition and physical activity metrics.
  • These findings support the concept that frailty domains can be quantified in children and adolescents with cardiac disease.

Conclusions:

  • Frailty domains are quantifiable in children and adolescents with cardiac disease using developmentally appropriate methods.
  • Children and adolescents with cardiac disease exhibit significant deficits in all five frailty domains when compared to healthy controls.
  • Larger, longitudinal studies are warranted to further investigate frailty in CCD and its potential to predict adverse health outcomes.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
583
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
342
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
608
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
179
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
349